It's time to shed some light on the importance of fungi in neonatal intensive care units: what do we know about the neonatal mycobiome?
- PMID: 38567073
- PMCID: PMC10985264
- DOI: 10.3389/fmicb.2024.1355418
It's time to shed some light on the importance of fungi in neonatal intensive care units: what do we know about the neonatal mycobiome?
Abstract
The 21st century, thanks to the development of molecular methods, including DNA barcoding, using Sanger sequencing, and DNA metabarcoding, based on next-generation sequencing (NGS), is characterized by flourishing research on the human microbiome. Microbial dysbiosis is perceived as a new pathogenetic factor for neonatal diseases. Fungi are crucial, but neglected, components of the neonatal microbiome, which, despite their low abundance, significantly impact morbidity and mortality rates of premature infants hospitalized in Neonatal Intensive Care Units (NICUs). The neonatal mycobiome's composition and effect on health remain poorly studied research areas. Our knowledge about neonatal mycobiome, composed of limited genera, is mainly based on research on the bacterial microbiome. We presume it is influenced by clinical factors, including prematurity, antibiotic therapy, and type of delivery. Understanding these risk factors may be useful in prevention strategies against dysbiosis and invasive fungal infections. Despite the methodological challenges resulting from the biology of the fungal cell, this topic is an attractive area of research that may contribute to more effective treatment, especially of newborns from risk groups. In this mini review, we discuss the current state of knowledge, research gaps, study difficulties, and future research directions on the neonatal mycobiome, concerning potential future clinical applications.
Keywords: DNA barcoding; fungal microbiome; microbial dysbiosis; neonatal intensive care unit; neonatal mycobiome; next generation sequencing; prematurity; vertical transmission.
Copyright © 2024 Wojciechowska, Salamon and Wróblewska-Seniuk.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Exploring the Skin Mycobiome in Very Preterm babies during the early neonatal period in a Neonatal Intensive Care Unit of India.Trop Doct. 2022 Apr;52(2):362-364. doi: 10.1177/00494755221077520. Epub 2022 Feb 7. Trop Doct. 2022. PMID: 35125017
-
Mycobiome in the Gut: A Multiperspective Review.Mediators Inflamm. 2020 Apr 4;2020:9560684. doi: 10.1155/2020/9560684. eCollection 2020. Mediators Inflamm. 2020. PMID: 32322167 Free PMC article. Review.
-
Fungal cutaneous microbiome and host determinants in preterm and term neonates.Pediatr Res. 2020 Aug;88(2):225-233. doi: 10.1038/s41390-019-0719-7. Epub 2019 Dec 9. Pediatr Res. 2020. PMID: 31816621
-
Development of the Human Mycobiome over the First Month of Life and across Body Sites.mSystems. 2018 Mar 6;3(3):e00140-17. doi: 10.1128/mSystems.00140-17. eCollection 2018 May-Jun. mSystems. 2018. PMID: 29546248 Free PMC article.
-
Fungi in Bronchiectasis: A Concise Review.Int J Mol Sci. 2018 Jan 4;19(1):142. doi: 10.3390/ijms19010142. Int J Mol Sci. 2018. PMID: 29300314 Free PMC article. Review.
References
-
- Alvarado-Socarras J. L., Vargas-Soler J. A., Franco-Paredes C., Villegas-Lamus K. C., Rojas-Torres J. P., Rodriguez-Morales A. J. (2021). A cluster of neonatal infections caused by Candida auris at a large referral center in Colombia. J. Pediatric. Infect. Dis. Soc. 10, 549–555. doi: 10.1093/jpids/piaa152, PMID: - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources